“…This is attributed to the lack of robust bioprocess control in the closed system "black box" bioreactor . Multiple bioprocess monitoring techniques exist, primarily originating in the biopharmaceutical bioreactor industry, that can quantitatively measure physicochemical process parameters, such as temperature, pH, dissolved O 2 , glucose concentration, and metabolic activity (Bluma et al, 2011;Rolfe, 2006;Starly and Choubey, 2008;Ward et al, 2013;Zhou et al, 2013). However, a direct transfer of the biopharmaceutical monitoring and control strategies to TE bioreactors is not straightforward.…”